PharmAthene to Hold Investor Call Regarding Merger with HAQ

Annapolis, Maryland (ots/PRNewswire) -

- New Common Stock Symbol is 'PIP'

What: PharmAthene, Inc. (Amex: PIP) to host a conference call to
discuss merger with HAQ.
When: Wednesday, August 8, 2007 1:00 PM EST.
How: In the US +1-877-879-6203/International +1-719-325-4760
Please refer to the Confirmation Code: 3318943
A playback of the call will be available until September 8, 2007
In the US +1-888-203-1112/ International +1-719-457-0820
Replay Passcode: 3318943
Contact: Erica Greenman
Hullin Metz & Co.
Office: +1-212-752-1044/ Mobile +1-917-822-7702
Erica@hmcllc.com

Additional Information

Pharmathene claims the protection of the safe harbor for
"forward-looking statements" within the meaning of the private
securities litigation reform act of 1995. Forward-looking statements
are statements that are not historical facts. Such forward-looking
statements, based upon the current beliefs and expectations of
management of PharmAthene regarding, among other things, the
potential determinations by a court of chancery in Delaware as to the
validity of the approval of the merger, which cannot be predicted
with certainty. No assurances can be given that other parties will
not oppose confirmation of such validity.

About PharmAthene, Inc.

PharmAthene was a privately-held biodefense company, was formed in
2001 to meet the critical needs of the United States by developing
biodefense products. PharmAthene is dedicated to the rapid
development of important and novel biotherapeutics to address
biological pathogens and chemicals that may be used as weapons of
bioterror. PharmAthene's lead programs include Valortim(TM) and
Protexia(R). For more information on PharmAthene, please visit its
website at www.PharmAthene.com. Following approval of the merger at
HAQ's Special Meeting of Stockholders held on Friday, August 3, 2007,
the name of PharmAthene was changed to "PharmAthene US Corporation."

Web site: http://www.PharmAthene.com

ots Originaltext: PharmAthene, Inc.
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Erica Greenman of Hullin Metz & Co., +1-212-752-1044, or
+1-917-822-7702, or Erica@hmcllc.com, for PharmAthene, Inc.


	hier anmelden...